Back to 
BNP Paribas Financial Markets
BNP Paribas Financial Markets
ALGS
8 quarters
Position history for BNP Paribas Financial Markets's holdings in Aligos Therapeutics, Inc.
Yes. BNP Paribas Financial Markets holds 3 shares of ALGS (Aligos Therapeutics), worth $17, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. BNP Paribas Financial Markets has held ALGS since Q3 2024, across 8 quarterly 13F filings.
Current Value
$17
Current Shares
3
Total Value Change
-$9
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of ALGS: Adage Capital Partners GP, L.L.C., Woodline Partners LP, Alyeska Investment Group, L.P., Vanguard Group Inc.